Heparin-binding motif mutations of human diamine oxidase allow the development of a first-in-class histamine-degrading biopharmaceutical

E. Gludovacz, K. Schuetzenberger, M. Resch, K. Tillmann, K. Petroczi, M. Schosserer, S. Vondra, S. Vakal, G. Klanert, J. Pollheimer, T.A. Salminen, B. Jilma, N. Borth, T. Boehm

Research output: Contribution to journalArticleScientificpeer-review

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Heparin-binding motif mutations of human diamine oxidase allow the development of a first-in-class histamine-degrading biopharmaceutical'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science